New drug darolutamide tested in Real-World prostate cancer study

NCT ID NCT04122976

Ongoing Disease control Sponsor: Bayer Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 23 times

Summary

This study tracks the safety and effectiveness of darolutamide in men with prostate cancer that has not spread but is no longer responding to standard hormone therapy. Over 800 participants are being observed in real-world clinics to see how well the drug works and what side effects occur. The goal is to understand how darolutamide performs outside of controlled trials.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Advanced Urology Institute

Daytona Beach, Florida, 32114, United States
Arizona Institute of Urology

Tucson, Arizona, 85704, United States
Associated Medical Professional Urology

Syracuse, New York, 13210, United States
Associated Urologists of NC

Raleigh, North Carolina, 27612, United States
Baylor Scott & White Medical Center - Temple

Temple, Texas, 76508, United States
Beacon Cancer Care

Beacon, New York, 83814, United States
Dukes Cancer Intitute Center for Prostate and Urologic Cancers

Durham, North Carolina, 27710, United States
First Urology, PSC

Jeffersonville, Indiana, 47130, United States
Genesis Comprehensive Prostate Cancer Center

San Diego, California, 92123, United States
Integrated Medical Professionals, PLLC

North New Hyde Park, New York, 11042, United States
Keystone Urology Specialists

Lancaster, Pennsylvania, 17601, United States
Manatee Medical Research Institute

Bradenton, Florida, 34205, United States
Many Locations

Multiple Locations, Argentina
Many Locations

Multiple Locations, Austria
Many Locations

Multiple Locations, Belgium
Many Locations

Multiple Locations, Brazil
Many Locations

Multiple Locations, Canada
Many Locations

Multiple Locations, China
Many Locations

Multiple Locations, Colombia
Many Locations

Multiple Locations, Denmark
Many Locations

Multiple Locations, France
Many Locations

Multiple Locations, Germany
Many Locations

Multiple Locations, Greece
Many Locations

Multiple Locations, Italy
Many Locations

Multiple Locations, Japan
Many Locations

Multiple Locations, Russia
Many Locations

Multiple Locations, Spain
Many Locations

Multiple Locations, Taiwan
MultiCare Institute for Research & Innovation

Tacoma, Washington, 98405, United States
New Jersey Urology

Englewood, New Jersey, 07631, United States
Oregon Urology Institutue

Springfield, Oregon, 01106, United States
Premier Medical Group of the Hudson Valley, PC

Poughkeepsie, New York, 12603, United States
Research by Design, LLC

Chicago, Illinois, 60643, United States
Southcoast Centers for Cancer Care

Fairhaven, Massachusetts, 02719, United States
The Urology Center of Colorado

Denver, Colorado, 80211, United States
University of Washington

Seattle, Washington, 98101, United States
Urology Centers of Alabama

Homewood, Alabama, 35209, United States
Urology San Antonio

San Antonio, Texas, 78229, United States
Urology of Virginia

Virginia Beach, Virginia, 23462, United States
Vanderbilt University Medical Center

Nashville, Tennessee, 37203, United States
Wichita Urology Group

Wichita, Kansas, 67206, United States

Conditions

Explore the condition pages connected to this study.

PROSTATE CANCER